Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
US 7,338,932 Lapsed on the fee recordLapsed Mar 4, 2020 on the fee record · From the USPTO record
20-year base term ended May 10, 2021
Third maintenance fee unpaid; grace period ended.
May 10, 2001
Mar 4, 2020
Mar 4, 2008
Apr 25, 2023
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 10, 2001, when the earliest non-provisional application in its chain was filed (this one was filed Nov 12, 2002); a parent in its chain could not be resolved (the next row) | May 10, 2021 | USPTO record |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | USPTO record |
| Patent term adjustment | +715 days, USPTO patent term adjustment record | Apr 25, 2023 | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 2 of 3 maintenance fees paid | lapsed Mar 4, 2020 | USPTO record |
| Computed term end | The steps above, in order | Mar 4, 2020 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.